SEC 13F Intelligence

Managers / Q2 2025 · view latest →

HUSSMAN STRATEGIC ADVISORS, INC.

CIK 0001179475 · 6021 UNIVERSITY BLVD., SUITE 490, ELLICOTT CITY, MD, 21043 · (410) 715-1130

Reported Value
$438M
Q2 2025
Positions
210
Filings on Record
30
2019–present window
Filed
Aug 5, 2025
original filing

Summary

Hussman Strategic Advisors, Inc. reported $438M in U.S.-listed holdings across 210 positions for Q2 2025.

Its largest position, AEM, represents 4.2% of the portfolio.

Compared with Q1 2025, the fund opened 81 new positions and exited 103.

Portfolio Metrics

Turnover
+48.8%
vs prior filed quarter
Top-10 Concentration
+21.1%
share of reported value
Largest Position
+4.2%
Agnico Eagle Mines
New / Exited
81 / 103
positions this quarter

Methodology: turnover is min(value bought, value sold) ÷ average reported value across the two quarters — value-based, so market moves inflate it slightly versus a share-based measure. Concentration and largest position are shares of the filing’s total reported value, options excluded. New/exited counts compare against the prior filed quarter. All figures derive solely from the fund’s 13F filings.

Reported Value by Quarter

13F Reported Value
Q4 ’18: $414MQ4 ’18Q1 ’19: $409MQ2 ’19: $358MQ3 ’19: $353MQ4 ’19: $314MQ4 ’19Q1 ’20: $371MQ2 ’20: $392MQ3 ’20: $378MQ4 ’20: $381MQ4 ’20Q1 ’21: $486MQ2 ’21: $483MQ3 ’21: $454MQ4 ’21: $456MQ4 ’21Q1 ’22: $515MQ3 ’22: $579MQ4 ’22: $614MQ1 ’23: $637MQ1 ’23Q2 ’23: $543MQ3 ’23: $524MQ4 ’23: $440MQ1 ’24: $430MQ1 ’24Q2 ’24: $363MQ3 ’24: $407MQ4 ’24: $338MQ1 ’25: $413MQ1 ’25Q2 ’25: $438MQ3 ’25: $462MQ4 ’25: $414MQ1 ’26: $463MQ1 ’26filingsflow.com

Portfolio Composition

By security type
Common Stock: 91.3%Other: 6.4%REIT: 0.9%ADR: 0.8%ETP: 0.5%
  • Common Stock · 91.3% · $400M
  • Other · 6.4% · $28M
  • REIT · 0.9% · $4M
  • ADR · 0.8% · $4M
  • ETP · 0.5% · $2M

Quarter-over-Quarter Changes full breakdown →

vs Q1 2025 (amended baseline)

IssuerMoveShare ΔShares nowValue ΔValue now
BBARRICK MNG CORPNEW+816.0K816.0K+$17M$17M
IDIINTERDIGITAL INCNEW+21.0K21.0K+$5M$5M
CTSHCOGNIZANT TECHNOLOGY SOLUTIONEW+52.5K52.5K+$4M$4M
GLGLOBE LIFE INCNEW+31.5K31.5K+$4M$4M
EPAMEPAM SYS INCNEW+21.0K21.0K+$4M$4M
GENPACT LIMITEDNEW+84.0K84.0K+$4M$4M
ALKERMES PLCNEW+126.0K126.0K+$4M$4M
NORWEGIAN CRUISE LINE HLDG LNEW+168.0K168.0K+$3M$3M

Value changes conflate price moves with buying and selling — share changes are the real signal. Share counts are not split-adjusted.

Holdings — Q2 2025

50 positions
#IssuerClass% PortfolioValueShares
1AEMAGNICO EAGLE MINES LTDhistory →COM4.16%$18M153.0K
2NEMNEWMONT CORPhistory →COM4.07%$18M306.0K
3BBARRICK MNG CORPhistory →COM SHS3.88%$17M816.0K
4UIUBIQUITI INChistory →COM1.58%$7M16.8K
5RGLDROYAL GOLD INChistory →COM1.45%$6M35.7K
6CHTRCHARTER COMMUNICATIONS INC Nhistory →CL A1.37%$6M14.7K
7CPBTHE CAMPBELLS COMPANYhistory →COM1.32%$6M189.0K
8CLCOLGATE PALMOLIVE COhistory →COM1.09%$5M52.5K
9IDIINTERDIGITAL INChistory →COM1.08%$5M21.0K
10CHECK POINT SOFTWARE TECH LTORD1.06%$5M21.0K
11EX9EXELIXIS INChistory →COM1.06%$5M105.0K
12TGTXTG THERAPEUTICS INChistory →COM1.04%$5M126.0K
13UNFIUNITED NAT FOODS INChistory →COM1.01%$4M189.0K
14HALOHALOZYME THERAPEUTICS INChistory →COM1.00%$4M84.0K
15INCYINCYTE CORPhistory →COM0.98%$4M63.0K
16UTHUNITED THERAPEUTICS CORP DELhistory →COM0.97%$4M14.7K
17INVAINNOVIVA INChistory →COM0.96%$4M210.0K
18CALMCAL MAINE FOODS INChistory →COM NEW0.96%$4M42.0K
19LBRDALIBERTY BROADBAND CORPhistory →COM SER A0.94%$4M42.0K
20CTSHCOGNIZANT TECHNOLOGY SOLUTIOhistory →CL A0.94%$4M52.5K
21TWLOTWILIO INChistory →CL A0.90%$4M31.5K
22GLGLOBE LIFE INChistory →COM0.89%$4M31.5K
23ICUIICU MED INChistory →COM0.89%$4M29.4K
24GLOBANT S ACOM0.87%$4M42.0K
25BKUBANKUNITED INChistory →COM0.85%$4M105.0K
26EPAMEPAM SYS INChistory →COM0.85%$4M21.0K
27GENPACT LIMITEDSHS0.84%$4M84.0K
28NVONOVO-NORDISK A Shistory →ADR0.83%$4M52.5K
29ALKERMES PLCSHS0.82%$4M126.0K
30DOLE PLCORD SHS0.81%$4M252.0K
31NORWEGIAN CRUISE LINE HLDG LSHS0.78%$3M168.0K
32AGIALAMOS GOLD INC NEWhistory →COM CL A0.77%$3M127.5K
33PEPPEPSICO INChistory →COM0.76%$3M25.2K
34HRMYHARMONY BIOSCIENCES HLDGS INhistory →COM0.76%$3M105.0K
35WEAWESTERN ALLIANCE BANCORPhistory →COM0.75%$3M42.0K
36DOCUDOCUSIGN INChistory →COM0.75%$3M42.0K
37GISGENERAL MLS INChistory →COM0.75%$3M63.0K
38MTBM & T BK CORPhistory →COM0.74%$3M16.8K
39DOCSDOXIMITY INChistory →CL A0.74%$3M52.5K
40CN2CATALYST PHARMACEUTICALS INChistory →COM0.73%$3M147.0K
41KGCKINROSS GOLD CORPhistory →COM0.73%$3M204.0K
42APPNAPPIAN CORPhistory →CL A0.72%$3M105.0K
43ASTHASTRANA HEALTH INChistory →COM NEW0.72%$3M126.0K
44HTDCORCEPT THERAPEUTICS INChistory →COM0.70%$3M42.0K
45PTCTPTC THERAPEUTICS INChistory →COM0.70%$3M63.0K
46OGM1COGENT COMMUNICATIONS HLDGShistory →COM NEW0.69%$3M63.0K
47AUPHAURINIA PHARMACEUTICALS INChistory →COM0.69%$3M357.0K
48MDPEDIATRIX MEDICAL GROUP INChistory →COM0.69%$3M210.0K
49BFHBREAD FINANCIAL HOLDINGS INChistory →COM0.69%$3M52.5K
50LULULULULEMON ATHLETICA INChistory →COM0.68%$3M12.6K

Filing History

QuarterReported ValuePositionsFiledTypeLinks
Q1 2026$463M268May 11, 202613F-HRchanges · EDGAR ↗
Q4 2025$414M252Feb 2, 202613F-HRchanges · EDGAR ↗
Q3 2025$462M270Nov 3, 202513F-HRchanges · EDGAR ↗
Q2 2025$438M210Aug 5, 202513F-HRchanges · EDGAR ↗
Q1 2025$413M232May 5, 202513F-HRchanges · EDGAR ↗
Q4 2024$338M234Feb 3, 202513F-HRchanges · EDGAR ↗
Q3 2024$407M216Nov 1, 202413F-HRchanges · EDGAR ↗
Q2 2024$363M232Aug 1, 202413F-HRchanges · EDGAR ↗
Q1 2024$430M216May 1, 202413F-HRchanges · EDGAR ↗
Q4 2023$440M222Feb 1, 202413F-HRchanges · EDGAR ↗
Q3 2023$524M296Nov 8, 202313F-HRchanges · EDGAR ↗
Q2 2023$543M294Aug 3, 202313F-HRchanges · EDGAR ↗
Q1 2023$637M330May 5, 202313F-HRchanges · EDGAR ↗
Q4 2022$614M311Feb 8, 202313F-HRchanges · EDGAR ↗
Q3 2022$579M308Nov 2, 202213F-HRchanges · EDGAR ↗
Q1 2022$515M332May 4, 202213F-HRchanges · EDGAR ↗
Q4 2021$456M319Jan 31, 202213F-HRchanges · EDGAR ↗
Q3 2021$454M316Nov 1, 202113F-HRchanges · EDGAR ↗
Q2 2021$483M336Aug 3, 202113F-HRchanges · EDGAR ↗
Q1 2021$486M325May 3, 202113F-HRchanges · EDGAR ↗
Q4 2020$381M270Feb 1, 202113F-HRchanges · EDGAR ↗
Q3 2020$378M260Nov 2, 202013F-HRchanges · EDGAR ↗
Q2 2020$392M259Jul 31, 202013F-HRchanges · EDGAR ↗
Q1 2020$371M271May 1, 202013F-HRchanges · EDGAR ↗
Q4 2019$314M201Jan 31, 202013F-HRchanges · EDGAR ↗
Q3 2019$353M197Oct 31, 201913F-HRchanges · EDGAR ↗
Q2 2019$358M183Jul 31, 201913F-HRchanges · EDGAR ↗
Q1 2019$409M241May 1, 201913F-HRchanges · EDGAR ↗
Q4 2018$414M261Feb 1, 201913F-HRchanges · EDGAR ↗

13F filings are due up to 45 days after quarter end, so holdings shown here lag the fund’s current book. Source: original SEC filing on EDGAR ↗.